Weak operational efficiency and declining liquidity are weighing on Greenbrier's performance, undermining its prospects.
|
![]() |
Weak operational efficiency and declining liquidity are weighing on Greenbrier's performance, undermining its prospects.
|
![]() |
CRS's third-quarter fiscal 2025 results are likely to reflect the impacts of solid end-market demand, offset by supply-chain challenges.
|
![]() |
Ecolab announces a 5% U.S. trade surcharge to offset rising costs.
|
![]() |
LVS' first-quarter performance is likely to have gained from the recovery of the Macao and Singapore markets and robust capital investment programs.
|
![]() |
TCBI's first-quarter 2025 results are affected by a rise in expenses and a decline in the loan balance. Yet, increased NII and fee income offer some support.
|
![]() |
DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the Diagnostics and Life Sciences segments are expected to have hurt.
|
![]() |
Tesla may have started the race, but BYD is setting the pace. Does this Chinese EV giant now hold an upper hand in this high-stakes race for electric dominance?
|
![]() |
GE's first-quarter results are likely to benefit from strength across its commercial and defense end markets. High costs and expenses are likely to have been spoilsport.
|
![]() |
Every week brings us big headlines, and there is nothing to suggest this will calm in the near term.
|
![]() |